News & Videos - US NASDAQ Stocks - English

Rising Cost-of-Living Pressures Make Return Policies Crucial for Retail Success, Reveals Manhattan Associates Study PR Newswire SYDNEY, Sept. 17, 2024 SYDNEY , Sept. 17, 2024 /PRNewswire/ -- As cost-of-living pressures mount and the post-End of Financial Year (EOFY) period settles in, the Australian retail landscape is being reshaped by a critical factor: return policies. New research from Manhattan Associates Inc . (NASDAQ: MANH ) reveals that Australian consumers are increasingly cautious with...

SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that John Koryl, CEO, and Ajay Gopal, CFO, will participate in a fireside chat at the Wells Fargo 7th Annual Consumer Conference on Thursday, September 19. Mr. Koryl and Mr. Gopal are scheduled to present at 10:15am PT (1:15pm ET). The event webcast details can be found on The RealReal’s investor website at...

DENVER, Sept. 16, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), please note that in the fifth paragraph of the release, the title for Dr. Ann Wells has been corrected to Chief Quality and Population Health Officer of InnovAge. The updated release follows: InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leading Program of All-inclusive Care for the Elderly (PACE) provider, has been selected...

Microsoft announces quarterly dividend increase and new share repurchase program PR Newswire REDMOND, Wash., Sept. 16, 2024 Annual shareholders meeting set for Dec. 10, 2024 REDMOND, Wash. , Sept. 16, 2024 /PRNewswire/ -- Microsoft Corp. on Monday announced that its board of directors declared a quarterly dividend of $0.83 per share, reflecting an 8 cent or 10% increase over the previous quarter's dividend. The dividend is payable Dec. 12, 2024 , to shareholders of record on Nov. 21, 2024 . The...

MGNX Deadline: MGNX Investors with Losses in Excess of $100K Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Sept. 16, 2024 NEW YORK , Sept. 16, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock or sellers of puts of MacroGenics, Inc. (NASDAQ: MGNX) between March 7, 2024 and May 9, 2024 , both dates inclusive (the "Class Period"), of the important September 24, 2024 lead plaintiff deadline. So what:...

CAMPBELL, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys’ IP revenue to over $1.5 billion, making Synopsys the second largest semiconductor IP company in the world. With three decades...

GROSSE POINTE FARMS, Mich., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Saga Communications, Inc. (Nasdaq - SGA) (the “Company” or “Saga”) today announced the promotions of Samuel D. Bush to Executive Vice President as well as continuing his position as Chief Financial Officer and Treasurer. Mr. Bush joined Saga in 1997 as Vice President, Chief Financial Officer and Treasurer later being promoted to Senior Vice President in 2002. Also announced today is the promotion of Wayne Leland from Senior...

The luxury vacation club is set to install Tonal’s revolutionary trainer in select vacation homes across the portfolio. Inspirato is excited to announce a new partnership with Tonal, the world’s smartest strength training system, to install the innovative Tonal trainer in select Inspirato vacation homes. Inspirato members are eligible for an exclusive discount on the purchase of their own Tonal trainer. This partnership is a reflection of Inspirato’s commitment to curating unforgettable...

ONTARIO, CA, Sept. 16, 2024 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the third quarter of 2024. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on September 16, 2024. The quarterly dividend will be payable on or about October 14, 2024 to shareholders of record as of September 30, 2024. “We are pleased to announce our 140 th consecutive...

WILMINGTON, Del., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix”) announced today that its board of directors (the “Board”) has decided to extend the date by which Bannix must consummate an initial business combination (the “Deadline Date”) from September 14, 2024 for an additional month, to October 14, 2024. As previously disclosed, at an annual meeting of its stockholders held on September 6, 2024, Bannix’ stockholders voted in favor of a proposal to amend...

Steel Dynamics Provides Third Quarter 2024 Earnings Guidance PR Newswire FORT WAYNE, Ind., Sept. 16, 2024 FORT WAYNE, Ind. , Sept. 16, 2024 /PRNewswire/ -- Steel Dynamics, Inc. (NASDAQ/GS: STLD) today provided third quarter 2024 earnings guidance in the range of $1.94 to $1.98 per diluted share. Comparatively, the company's sequential second quarter 2024 earnings were $2.72 per diluted share, and prior year third quarter earnings were $3.47 per diluted share. Third quarter 2024 profitability...

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements PR Newswire NEW YORK, Sept. 16, 2024 Efforts include appointment of seasoned biotech investor Sundeep Agrawal , M.D. to board to replace departing directors NEW YORK , Sept. 16, 2024 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that, as part of...

First Financial Bankshares Announces the Election of Brian D. Goodrich, EVP, General Counsel PR Newswire ABILENE, Texas, Sept. 16, 2024 ABILENE, Texas , Sept. 16, 2024 /PRNewswire/ -- First Financial Bankshares, Inc. (NASDAQ: FFIN) (the "Company," "First Financial Bankshares," "we", "us" or "our") has announced the election of Brian D. Goodrich as Executive Vice President and General Counsel. "We are delighted to welcome Brian to Abilene and to the Company's executive management team as the...

SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, announced the appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer, effective today. Dr. Perney brings an extensive track record of expertise and leadership in Regulatory, Product Development and Quality in the industry to the...

CARMEL, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the closing of its previously announced upsized initial public offering of 11,730,000 of its common stock at a price to the public of $16.00 per share, which includes 1,530,000 shares issued upon...

SAN CARLOS, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven fintech, today announced that it will participate in the upcoming Sidoti September Virtual Investor Conference. Oportun’s Chief Executive Officer, Raul Vazquez, and Chief Financial Officer & Chief Administrative Officer, Jonathan Coblentz, will present and participate in investor meetings at the conference. The presentation will begin at 2:30 pm ET on September 18th and can be accessed live at this...

WATERTOWN, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 9:45 a.m. ET. To register for the live webcast, please click here . The webcast will also be available on the Company’s...

REDWOOD CITY, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that management will present at the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 8:00 AM Eastern Time. A live audio webcast and replay of the presentation will be available in the Investors section on the Company’s website at...

SEATTLE, WA / ACCESSWIRE / September 16, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 9,090,910 shares of its common stock or pre-funded warrants in lieu thereof and (ii)...

BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for patients with solid tumors, today announced the closing of its initial public offering of 20,125,000 shares of its common stock at a public offering price of $18.00 per share, which includes 2,625,000 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares of...